Strides Shasun's subsidiary Strides Pharma Global Pte, Singapore has received US FDA tentative approval for its para IV filing of Fingolimod Capsules, 0.5 mg. India Infoline, 2 months ago
Strides Shasun receives USFDA tentative nod for Fingolimod - DNA, 2 months ago
1 images for "para iv"
Natco and Mylan believe that they are the first companies to have filed a substantially complete abbreviated new drug application containing a Para-IV certification for a 3 times per week Glatiramer Acetate Injection 40 mg/mL, and expect 180 days of marketing ...Money Control, 2 months ago
on your WebpageAdd Widget >Get your members hooked!